All Notifications

Thyrocare Technologies has expanded its presence in Northern India by acquiring the pathology bus...

Veeda, providing a broad range of services across most aspects of the drug development & drug launch throughout global markets has raised capital from Sixth Sense Ventures & others. 

Founded in 2004, Veeda has grown from a single facility in 2004 to now having 4 facilities with a capability to process 1 lakh+ samples monthly. Veeda provides services across drug value chain incl BA/BE studies, full suits of Clinical trials, pharmacokinetics studies & trials in generic molecules, NCEs, large molecules & Biosimilars. 

Till date, Veeda has conducted over 3,500 trials, developed 1,000+ bio-analytical methods spread across generics, NCEs & Biosimilars & completed 85 successful regulatory audits with UK-MHRA, ANVISA & DCGI. The capital raised will be used towards Veeda’s objective of backward as well as forward integration by evaluating inorganic growth opportunities.

Starting soon, Cochin International Airport (CIAL) will introduce a new self-immigration process...

Financials of Hindusthan Engineering & Industries Limited Unlisted Shares are updated for 2023

Financials of Electrosteel Steels Limited Unlisted Shares are updated for 2024

Financials of Hindusthan Engineering & Industries Limited Unlisted Shares are updated for 2022

Financials of Royalcare Super Speciality Hospitals are updated for 2023

Financials of Royalcare Super Speciality Hospitals are updated for 2022

Financials of Royalcare Super Speciality Hospitals are updated for 2021

approval of the resolution plan submitted by IndusInd International Holdings Ltd